PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)
Authors:
- Isabel SyndikusISIsabel Syndikus
- Clare CruickshankCCClare Cruickshank
- John StaffurthJSJohn Staffurth
- Alison TreeATAlison Tree
- Ann HenryAHAnn Henry
- Olivia NaismithONOlivia Naismith
- Helen MaylesHMHelen Mayles
- Nicola SnelsonNSNicola Snelson
- Shama HassanSHShama Hassan
- Stephanie BrownSBStephanie Brown
- Nuria PortaNPNuria Porta
- Clare GriffinCGClare Griffin
Open Access
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 25, 22-28
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK (CRUK/16/018)
- Cancer Research UK (A20658)
This publication has 26 references indexed in Scilit:
- Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate CancerJournal of Clinical Oncology, 2016
- PI-RADS version 2: what you need to knowClinical Radiology, 2015
- High-risk prostate cancer—classification and therapyNature Reviews Clinical Oncology, 2014
- Direct 2-Arm Comparison Shows Benefit of High-Dose-Rate Brachytherapy Boost vs External Beam Radiation Therapy Alone for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancerRadiotherapy and Oncology, 2012
- High-Dose-Rate Brachytherapy Alone for Localized Prostate Cancer in Patients at Moderate or High Risk of Biochemical RecurrenceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without 18F-choline PET-CT detected simultaneous integrated boostRadiation Oncology, 2012
- Dose Escalation Improves Cancer-Related Events at 10 Years for Intermediate- and High-Risk Prostate Cancer Patients Treated With Hypofractionated High-Dose-Rate Boost and External Beam RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Phase II Trial of Radiation Dose Escalation With Conformal External Beam Radiotherapy and High-Dose-Rate Brachytherapy Combined With Long-Term Androgen Suppression in Unfavorable Prostate Cancer: Feasibility ReportInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- GSRS?A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer diseaseDigestive Diseases and Sciences, 1988